51 – 60 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
(
- Contribution to journal › Article
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
- 2020
-
Mark
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism
(
- Contribution to journal › Article
-
Mark
Optimizing Treatment in Undertreated Late-Stage Parkinsonism : A Pragmatic Randomized Trial
(
- Contribution to journal › Article
-
Mark
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis : The COVID-19 Experience
(
- Contribution to journal › Scientific review
-
Mark
Levodopa infusion in Parkinson's disease : Individual quality of life
(
- Contribution to journal › Article
-
Mark
The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
(
- Contribution to journal › Article
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
(
- Contribution to journal › Article
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article